Julia Krämer

6PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersOrthodontics and dentofacial orthopaedicsMedical infection agents (incl. prions)Major global burdens of diseaseNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2026
Distinct Multiomic Signatures of Environmental Exposure Drive Immune Dysregulation and Disease Activity in Early Multiple Sclerosis.

|Aug 08, 2025
Oromandibular Dystonia and Dysphagia in Hyperglycemic Brainstem Dysfunction.

Gero Lueg, Timm Westhoff, Martin Fruth

|Jun 19, 2024
Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis.

Julia Krämer, Carolin Balloff, Margit Weise

|May 10, 2019
Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center.

Lisa Langenbruch, Julia Krämer, Sati Güler

|Apr 14, 2017
Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?

Julia Krämer, Jan-Gerd Tenberge, Ingo Kleiter

Pageof 1

Frequent Collaborators

2 joint publications

Heinz Wiendl

1 joint publications

Alex Hartmann

1 joint publications

Martin Kerschensteiner

1 joint publications

Marius Ringelstein